Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AAV.EpoR76E
- Development stage
- Preclinical
- Lead developer
- University of Iowa
- Modality
- Recombinant Proteins and Enzymes, Gene Therapies
- Administration
- Intramuscular
01
Overview
**AAV.EpoR76E is a gene therapy consisting of an adeno-associated viral (AAV) vector encoding a modified form of erythropoietin, EpoR76E, in which the arginine at position 76 is replaced by glutamate. EpoR76E retains neuroprotective and neurotrophic activities but lacks erythropoietic (blood-forming) activity, reducing risk of increased hematocrit and related side effects. The therapy is delivered via intramuscular injection and yields sustained systemic expression of EpoR76E. It has been shown in preclinical models to prevent cognitive decline, neuronal loss, synaptic protein loss, and amyloid-β accumulation in Alzheimer's disease models, and also to protect dopaminergic neurons in Parkinson’s disease models and retinal ganglion cells in glaucoma models.**[1][5]
- Other names
- AAV-EpoR76EAAV-EpoR-76EAAV-EpoR 76EAAV2/5.CMV.EpoR76E
02
Targets
INSRR (Insulin receptor-related receptor)
Beyond the preview
Go deeper on AAV.EpoR76E.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AAV.EpoR76E.